Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis

BACKGROUND: There is no standard second-line treatment for patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma (EP-PD-NEC). This study explored data evaluating second-line treatment in these patients. METHODS: A search of MEDLINE and EMBASE identified studies report...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Mairéad G., Frizziero, Melissa, Jacobs, Timothy, Lamarca, Angela, Hubner, Richard A., Valle, Juan W., Amir, Eitan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222242/
https://www.ncbi.nlm.nih.gov/pubmed/32426044
http://dx.doi.org/10.1177/1758835920915299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222242/
https://www.ncbi.nlm.nih.gov/pubmed/32426044
http://dx.doi.org/10.1177/1758835920915299

Ejemplares similares